Literature DB >> 29844643

Anti-Inflammatory Effect of Gallic Acid-Eluting Stent in a Porcine Coronary Restenosis Model.

Kyung Seob Lim1,2,3,4, Jun-Kyu Park5, Myung Ho Jeong1,2,3,6, In Ho Bae1,2,3, Dae Sung Park1,2,3, Jae Won Shim1,2,3, Jung Ha Kim1,2,3, Hyun Kuk Kim7, Sung Soo Kim7, Doo Sun Sim2,3, Young Joon Hong2,3, Ju Han Kim2,3, Youngkeun Ahn2,3.   

Abstract

BACKGROUND: Gallic acid (3,4,5-trihydroxybenzoic acid) is a natural polyphenol and strong natural antioxidant found abundantly in red wine and green tea. The aim of this study was to examine the anti-inflammatory effect of a novel gallic acid-eluting stent in a porcine coronary restenosis model.
METHODS: Fifteen pigs were randomized into three groups; in which a total of 30 coronary arteries (10 in each group) were implanted with gallic acid-eluting stents (GESs, n = 10), gallic acid and sirolimus-eluting stents (GSESs, n = 10), or sirolimus-eluting stents (SESs, n = 10). Histopathologic analysis was performed 28 days after stenting.
RESULTS: There were no significant differences in injury score and fibrin score among the groups, however there were significant differences in the internal elastic lamina (4.0 ± 0.83 mm2 in GES vs. 3.0 ± 0.53 mm2 in GSES vs. 4.6 ± 1.43 mm2 in SES, p < 0.0001), lumen area (2.3 ± 0.49 mm2 in GES vs. 1.9 ± 0.67 mm2 in GSES vs. 2.9 ± 0.56 mm2 in SES, p < 0.0001), neointimal area (1.7 ± 0.63 mm2 in GES vs. 1.1 ± 0.28 mm2 in GSES vs. 1.7 ± 1.17 mm2 in SES, p < 0.05), and percent area of stenosis (42.4% ± 9.22% in GES vs. 38.2% ± 12.77% in GSES vs. 33.9% ± 15.64% in SES, p < 0.05). The inflammation score was significantly lower in the GES and GSES groups compared to that in the SES group [1.0 (range: 1.0 to 2.0) in GES vs. 1.0 (range: 1.0 to 1.0) in GSES vs. 1.5 (range: 1.0 to 3.0) in SES, p < 0.05].
CONCLUSIONS: The GES group had a greater percent area of stenosis than the SES group. Although gallic acid in the GES and GSES groups did not show a synergistic effect in suppressing neointimal hyperplasia, it resulted in greater inhibition of the inflammatory reaction in the porcine coronary restenosis model than in the SES group.

Entities:  

Keywords:  Inflammation; Percutaneous coronary intervention; Restenosis; Stent

Year:  2018        PMID: 29844643      PMCID: PMC5968338          DOI: 10.6515/ACS.201805_34(3).20171204A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  42 in total

1.  Trading restenosis for thrombosis? New questions about drug-eluting stents.

Authors:  Miriam Shuchman
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

2.  Gallic acid induces vascular smooth muscle cell death via hydroxyl radical production.

Authors:  X Qiu; G Takemura; M Koshiji; Y Hayakawa; M Kanoh; R Maruyama; Y Ohno; S Minatoguchi; S Akao; K Fukuda; T Fujiwara; H Fujiwara
Journal:  Heart Vessels       Date:  2000       Impact factor: 2.037

3.  Comparison of Clinical Outcomes in Patients Undergoing Coronary Intervention with Drug-Eluting Stents or Bare-Metal Stents: A Nationwide Population Study.

Authors:  Shih-Hsien Sung; Tzu-Ching Chen; Hao-Min Cheng; Jia-Chun Lee; Hui-Chu Lang; Chen-Huan Chen
Journal:  Acta Cardiol Sin       Date:  2017-01       Impact factor: 2.672

Review 4.  Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.

Authors:  Giuseppe De Luca; Maurits T Dirksen; Henning Kelbæk; Leif Thuesen; Marteen A Vink; Christoph Kaiser; Tania Chechi; Gaia Spaziani; Emilio Di Lorenzo; Harry Suryapranata; Gregg W Stone
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

5.  Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

Authors:  Marie-Claude Morice; Antonio Colombo; Bernhard Meier; Patrick Serruys; Corrado Tamburino; Giulio Guagliumi; Eduardo Sousa; Hans-Peter Stoll
Journal:  JAMA       Date:  2006-02-22       Impact factor: 56.272

6.  Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model.

Authors:  Hui-Lian Che; In-Ho Bae; Kyung Seob Lim; In Taek Song; Haeshin Lee; Muthunarayanan Muthiah; Ran Namgung; Won Jong Kim; Dong-Gon Kim; Youngkeun Ahn; Myung-Ho Jeong; In-Kyu Park
Journal:  Biomaterials       Date:  2012-08-30       Impact factor: 12.479

7.  Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.

Authors:  Emilio Di Lorenzo; Rosario Sauro; Attilio Varricchio; Giannignazio Carbone; Giuliana Cortese; Michele Capasso; Tonino Lanzillo; Fiore Manganelli; Ciro Mariello; Francesco Siano; Maria Rosaria Pagliuca; Giovanni Stanco; Giuseppe Rosato; Giuseppe De Luca
Journal:  Circulation       Date:  2009-08-31       Impact factor: 29.690

8.  Artemisinin attenuates platelet-derived growth factor BB-induced migration of vascular smooth muscle cells.

Authors:  Kang Pa Lee; Eun-Seok Park; Dae-Eun Kim; In-Sik Park; Jin Tack Kim; Heeok Hong
Journal:  Nutr Res Pract       Date:  2014-08-30       Impact factor: 1.926

9.  Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model.

Authors:  Suyoung Jang; Myung Ho Jeong; Kyung Seob Lim; In Ho Bae; Jun-Kyu Park; Dae Sung Park; Jae Won Shim; Jung Ha Kim; Hyun Kuk Kim; Doo Sun Sim; Young Joon Hong; Youngkeun Ahn; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2016-12-27       Impact factor: 3.243

10.  Mechanical and Histopathological Comparison between Commercialized and Newly Designed Coronary Bare Metal Stents in a Porcine Coronary Restenosis Model.

Authors:  Kyung Seob Lim; In Ho Bae; Jung Ha Kim; Dae Sung Park; Jong Min Kim; Jung Hyun Kim; Doo Sun Sim; Young Joon Hong; Myung Ho Jeong
Journal:  Chonnam Med J       Date:  2013-04-25
View more
  4 in total

Review 1.  Anti-inflammatory and analgesic properties of Moroccan medicinal plants: Phytochemistry, in vitro and in vivo investigations, mechanism insights, clinical evidences and perspectives.

Authors:  Abdelhakim Bouyahya; Fatima-Ezzahrae Guaouguaou; Nasreddine El Omari; Naoual El Menyiy; Abdelaali Balahbib; Mohamed El-Shazly; Youssef Bakri
Journal:  J Pharm Anal       Date:  2021-07-13

2.  Chronic Staphylococcus aureus Superantigen Toxic Shock Syndrome Toxin-1 Exposure Accelerates the Progression of Atherosclerosis in Rabbits.

Authors:  Huanqiang Zhao; Lei Chen; Chunyan He; Shaobo Li; Han Yang; Xiaogang Xu; Fupin Hu; Zelin Cui; Qingzhong Liu
Journal:  Acta Cardiol Sin       Date:  2020-01       Impact factor: 2.672

3.  Serum Endocan Levels Predict Drug-Eluting Stent Restenosis in Patients with Stable Angina Pectoris.

Authors:  Ayhan Küp; Cüneyt Toprak; Emrah Bayam; Servet İzcı; Abdulkadir Uslu; Mehmet Çelık; İsmail Balaban; Sinan Cerşıt; Süleyman Barutçu; Pınar Demir Gündoğmuş
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

4.  Beneficial Effects of Hydroalcoholic Extract from Rosa Roxburghii Tratt Fruit on Hyperlipidemia in High-Fat-Fed Rats.

Authors:  Pin-Hsin Wu; Samuel Chieng-Haw Han; Meng-Hsiu Wu
Journal:  Acta Cardiol Sin       Date:  2020-03       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.